Responses
Regular and young investigator award abstracts
Clinical trials in progress
317 A phase 1/1b study of SBT6050, a HER2-directed monoclonal antibody conjugated to a toll-like receptor 8 agonist, in subjects with advanced HER2-expressing solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.